Copyright 2009 Medical News Today Latest Conferences News From Medical News Today. http://www.medicalnewstoday.com/sections/conferences/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Fri, 20 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/171650.php http://www.medicalnewstoday.com/articles/171650.php The U.N. World Summit on Food Security ended Wednesday in Rome with Food and Agriculture Organization (FAO) head Jacques Diouf calling for the global community to shift the fight against global hunger from "words to action," Agence France-Press reports. Water - Air Quality / Agriculture Fri, 20 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/171661.php http://www.medicalnewstoday.com/articles/171661.php A workshop on "Neuroeconomics and Endocrinological Economics," being held Nov. 20 and 21 at UC Davis, will be the first to bring together experts in neuroscience, economics and hormone physiology in one event, according to organizers. Neuroeconomics has emerged as a new field in recent years, as both economists and neuroscientists have used brain scanning technology such as functional magnetic resonance imaging to investigate how people make decisions. Neurology / Neuroscience Fri, 20 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/171662.php http://www.medicalnewstoday.com/articles/171662.php Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next level. Cancer / Oncology Thu, 19 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/171471.php http://www.medicalnewstoday.com/articles/171471.php Male infertility and tackling falling birth rates across Europe will be among the topics addressed at this year's British Andrology Society's annual conference at Queen's University in Belfast. World leaders in the field of andrology - the study of male reproduction - will meet at Queen's this week (Thursday and Friday) to discuss the latest developments in the field of fertility including the potential to create artificial sperm from stem cells. Fertility Thu, 19 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/171529.php http://www.medicalnewstoday.com/articles/171529.php Alarming trends captured in clinical study metrics show the glaring discrepancy between the miniscule number of sites that are able to enroll the amount of patients study sponsors are requesting and the amount of sites that cannot. This enrollment inability leads to trial stoppages, lost revenue and most importantly the delay of new treatments used to combat diseases that are available for the population. Conferences Wed, 18 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171281.php http://www.medicalnewstoday.com/articles/171281.php Mersana Therapeutics, a platform-based cancer therapeutics company, announced additional preliminary results from an ongoing Phase 1 study of its lead development candidate, XMT-1001, in patients with advanced solid tumors. The results were presented in a poster session at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics in Boston, MA November 15-19, 2009. Cancer / Oncology Tue, 17 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/171165.php http://www.medicalnewstoday.com/articles/171165.php The electrical measurements on the electrocardiogram can often mislead physicians in diagnosing the heart condition left ventricular hypertrophy, causing other screening tests to be ordered before a definitive conclusion can be made, according to a Henry Ford Hospital study. Cardiovascular / Cardiology Tue, 17 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171117.php http://www.medicalnewstoday.com/articles/171117.php WHAT: The Seventh International Chronic Total Occlusion (CTO) Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions. Cardiovascular / Cardiology Tue, 17 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171118.php http://www.medicalnewstoday.com/articles/171118.php The American Medical Informatics Association (AMIA) opened its Annual Symposium on Biomedical and Health Informatics with more than 2,000 members and registrants gathered at the Hilton San Francisco to exchange new information, best practices, and cutting-edge thinking on an array of topics in this burgeoning health care field. Opening the symposium was Mark D. IT / Internet / E-mail Tue, 17 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171121.php http://www.medicalnewstoday.com/articles/171121.php Many heart attack patients have high levels of cardiac biomarkers in the blood for several months after leaving the hospital, with more shortness of breath and chest pain, according to a Henry Ford Hospital study. The study examined a subset of patients in a 4,500-patient heart attack registry from 24 24 U.S. hospitals and found: 9 percent had elevated levels of the biomarker troponin (TnT) after six months. Cardiovascular / Cardiology Tue, 17 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/171096.php http://www.medicalnewstoday.com/articles/171096.php Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH), reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Prostate / Prostate Cancer Sat, 14 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170980.php http://www.medicalnewstoday.com/articles/170980.php Speedus Corp. (Nasdaq: SPDE) announced that it will be releasing a free trial version of its Zargis Cardioscan software during the American Heart Association's 2009 Scientific Sessions conference, taking place this November 15-17 in Orlando. Cardiovascular / Cardiology Sat, 14 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170962.php http://www.medicalnewstoday.com/articles/170962.php Clinical studies suggest that advanced treatments like intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) are enabling radiation oncologists to enhance post-treatment health-related quality of life for patients with head and neck cancer. In an educational session for radiotherapy professionals, delivered by two noted experts during the annual meeting of the American Society for Radiation Oncology (ASTRO) in Chicago last week, Avraham Eisbruch, M.D. Cancer / Oncology Fri, 13 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170769.php http://www.medicalnewstoday.com/articles/170769.php Getting regulatory agency approval for a new drug was once the end goal of pharmaceutical drug development, but in today's healthcare environment where governments increasingly determine price and the availability of drugs to patients through formulary designation, market access has become the "fourth hurdle" in successfully bringing a drug to market. Pharma Industry / Biotech Industry Fri, 13 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170816.php http://www.medicalnewstoday.com/articles/170816.php Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers. HIV / AIDS Thu, 12 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170762.php http://www.medicalnewstoday.com/articles/170762.php Phillip A. Sharp, a world leader of research in molecular biology and biochemistry and an institute professor at the Massachusetts Institute of Technology, has been named winner of the American Society for Biochemistry and Molecular Biology Herbert Tabor/Journal of Biological Chemistry Lectureship. Sharp will give his award lecture, titled "The Biology of small RNAs," at the 2010 annual meeting at 6 p.m. Saturday, April 24, in Anaheim, Calif. Cancer / Oncology Thu, 12 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170677.php http://www.medicalnewstoday.com/articles/170677.php Viron Therapeutics Inc., a biopharmaceutical company pioneering the development of viral protein therapeutics, announced that the Company's research collaborator, Dr. Jean-Claude Tardif, Director of the Research Center at the Montreal Heart Institute, will present data from a Phase IIa clinical trial evaluating VT-111 at the American Heart Association (AHA) Scientific Sessions 2009 conference. The conference will take place in Orlando, Florida from November 14 to 18, 2009. Heart Disease Thu, 12 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170688.php http://www.medicalnewstoday.com/articles/170688.php Boston Scientific Corporation (NYSE: BSX) announced its schedule of events at the 38th annual Global Congress for Minimally Invasive Gynecology (AAGL), which runs from November 15-19 in Orlando, Florida. Women's Health / Gynecology Wed, 11 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170630.php http://www.medicalnewstoday.com/articles/170630.php Emory University Rollins School of Public Health researchers will present Nov. 11 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that found reduced absenteeism among employees participating in a large-scale worksite wellness program. Additional public health research findings from Emory scientists are highlighted below. Preventive Medicine Wed, 11 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170537.php http://www.medicalnewstoday.com/articles/170537.php WHAT: A day-long symposium will be held at the National Institutes of Health (NIH), Thursday, November 12, to mark the American Chemical Society's designation of the deciphering of the genetic code as a National Historic Chemical Landmark. The symposium, Genes to Proteins: Decoding Genetic Information, will feature several prominent genomic researchers and will honor Marshall W. Nirenberg, Ph.D. Genetics Wed, 11 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170542.php http://www.medicalnewstoday.com/articles/170542.php As African nations are poised to undergo the highest increase in the rate of tobacco use among developing countries, nearly 90 percent of people on the continent remain without meaningful protection from secondhand smoke, according to a new report released at a regional cancer conference. The report, Global Voices: Rebutting the Tobacco Industry, Winning Smokefree Air, points to signs of hope, however. Smoking / Quit Smoking Tue, 10 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170421.php http://www.medicalnewstoday.com/articles/170421.php Dana Filoti of the University of New Hampshire will present thin films of silver and copper she has developed that can kill bacteria and may one day help to cut down on hospital infections. The antimicrobial properties of silver and copper have been known for centuries -- last year, the U.S. Environmental Protection Agency officially registered copper alloys, allowing them to be marketed with the label "kills 99.9% of bacteria within two hours. Infectious Diseases / Bacteria / Viruses Tue, 10 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170422.php http://www.medicalnewstoday.com/articles/170422.php Eric Shaqfeh studies blood at Stanford University, using computer models that simulate how the fluid and the cells it contains move around. On November 11 at a meeting of the scientific society AVS, he will present his latest unpublished findings from two studies. One shows how components in blood line up to prepare for healing; the other demonstrates the best shape to use for man-made nanoparticles that target cancers -- a surfboard. Cancer / Oncology Tue, 10 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170424.php http://www.medicalnewstoday.com/articles/170424.php Of the many characteristic traits a drug can have, one of the most desirable is the ability for a drug to be swallowed and absorbed into the bloodstream through the gut. Some drugs, like over-the-counter aspirin, lend themselves to this mode of delivery and are trivial to take. They can be pressed into a pill and swallowed. Other drugs cannot be swallowed and must be administered instead through more complicated routes. Insulin, for instance, must be injected. Medical Devices / Diagnostics Tue, 10 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170426.php http://www.medicalnewstoday.com/articles/170426.php Tooth enamel is the hardest material in the human body because it's made almost entirely of minerals. As tough as it may be, however, enamel can be broken down by bacteria, forming cavities and eventually destroying the tooth. That's why dentists repair cavities by filling them with a material to replace the lost enamel. The most common such restorative is a material invented in the 19th-century known as amalgam -- the classic silver-black fillings many people have. Dentistry